Bobircă, A.; Bobircă, F.; Ancuța, I.; Florescu, A.; Bojincă, M.; Muscă, A.; Florescu, D.N.; Florescu, L.M.; Sima, R.M.; Florescu, A.;
et al. COVID-19—A Trigger Factor for Severe Immune-Mediated Thrombocytopenia in Active Rheumatoid Arthritis. Life 2022, 12, 77.
https://doi.org/10.3390/life12010077
AMA Style
Bobircă A, Bobircă F, Ancuța I, Florescu A, Bojincă M, Muscă A, Florescu DN, Florescu LM, Sima RM, Florescu A,
et al. COVID-19—A Trigger Factor for Severe Immune-Mediated Thrombocytopenia in Active Rheumatoid Arthritis. Life. 2022; 12(1):77.
https://doi.org/10.3390/life12010077
Chicago/Turabian Style
Bobircă, Anca, Florin Bobircă, Ioan Ancuța, Anca Florescu, Mihai Bojincă, Alice Muscă, Dan Nicolae Florescu, Lucian Mihai Florescu, Romina Marina Sima, Alesandra Florescu,
and et al. 2022. "COVID-19—A Trigger Factor for Severe Immune-Mediated Thrombocytopenia in Active Rheumatoid Arthritis" Life 12, no. 1: 77.
https://doi.org/10.3390/life12010077
APA Style
Bobircă, A., Bobircă, F., Ancuța, I., Florescu, A., Bojincă, M., Muscă, A., Florescu, D. N., Florescu, L. M., Sima, R. M., Florescu, A., & Mușetescu, A. E.
(2022). COVID-19—A Trigger Factor for Severe Immune-Mediated Thrombocytopenia in Active Rheumatoid Arthritis. Life, 12(1), 77.
https://doi.org/10.3390/life12010077